Roger Y. Dodd
YOU?
Author Swipe
View article: An international survey on measures to prevent transfusion‐transmitted infectious diseases—study results 2: Testing and donor vigilance
An international survey on measures to prevent transfusion‐transmitted infectious diseases—study results 2: Testing and donor vigilance Open
Background and Objectives The results of a global survey on blood safety measures to prevent transfusion‐transmitted infectious diseases (TTIDs) were analysed, focusing on TTID testing requirements, practices and associated donor actions (…
View article: Urban versus rural blood donors in the United States and the relationship with transfusion‐transmissible infections
Urban versus rural blood donors in the United States and the relationship with transfusion‐transmissible infections Open
Introduction Most US blood donations are from donors living in urban areas. Demographics and infectious disease prevalence may vary in urban versus rural areas. We assessed demographic and transfusion‐transmissible infection (TTI) prevalen…
View article: Transfusion‐transmissible coinfections among <scp>US</scp> blood donors
Transfusion‐transmissible coinfections among <span>US</span> blood donors Open
Background Transfusion‐transmissible infection (TTI) prevalence among US blood donors has been widely documented. Here we estimate the prevalence of donors presenting with ≥2 TTIs (multiple infections past or present referred to as coinfec…
View article: Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses, December 2019 to July 2020
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses, December 2019 to July 2020 Open
Background The first coronavirus disease 2019 (COVID-19) case in the United States was recognized on 19 January 2020, but the time of introduction of the virus into the United States is unknown. An existing sample cohort was examined for s…
View article: Changes in transfusion‐transmissible infection prevalence and demographics among <scp>US</scp> blood donors during the <scp>COVID</scp>‐19 pandemic
Changes in transfusion‐transmissible infection prevalence and demographics among <span>US</span> blood donors during the <span>COVID</span>‐19 pandemic Open
Background The COVID‐19 pandemic impacted the US blood supply. We compared blood donor demography and infectious disease prevalence before and during the pandemic using a large multicenter database. Methods Data were categorized as “Before…
View article: Absence of evidence of transfusion transmission risk of Creutzfeldt‐Jakob disease in the United States: Results froma 28‐year lookback study
Absence of evidence of transfusion transmission risk of Creutzfeldt‐Jakob disease in the United States: Results froma 28‐year lookback study Open
Background For many years, there has been concern about the risk of transmission of classic forms of Creutzfeldt‐Jakob disease (CJD) by blood transfusion, particularly after the recognition of such transmission of variant CJD (vCJD). We re…
View article: Syphilis seroprevalence and incidence in <scp>US</scp> blood donors from 2020 to 2022
Syphilis seroprevalence and incidence in <span>US</span> blood donors from 2020 to 2022 Open
Background HIV, HBV, and HCV infections for ~60% of the US blood supply are monitored by TTIMS with syphilis added in 2020. Study Design and Methods Data were compiled from October 2020 to September 2022. Syphilis prevalence was estimated …
View article: Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United States
Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United States Open
We evaluated antibodies to the nucleocapsid protein of SARS-CoV-2 in a large cohort of blood donors in the United States who were recently infected with the virus. Antibodies to the nucleocapsid protein of SARS-CoV-2 indicate previous infe…
View article: A Longitudinal Study of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response in a Subset of United States Blood Donors
A Longitudinal Study of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response in a Subset of United States Blood Donors Open
Background Blood donors were tested for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); resulting antibody levels were monitored over time. Methods Donors reactive to anti-SARS-CoV-2 spike protein (S1-total anti…
View article: Issue Information
Issue Information Open
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO
View article: Paid platelet donors: Points to consider
Paid platelet donors: Points to consider Open
Is there a case that there are medically urgent, periodic platelet shortages, and will they increase in the future? Does overall platelet demand exceed supply and how is this managed? Should it be a surprise that periodic shortages occur f…
View article: Reviews of "SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline"
Reviews of "SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline" Open
Reviews of "SARS-CoV-2 seroprevalence survey estimates are a ected by anti-nucleocapsid antibody decline
View article: Review 2: "SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline"
Review 2: "SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline" Open
This study cautiously asserts that the outcome of a seroprevalence study is impacted by the declining prevalence rate, which impacts the sensitivity. Reviewers suggest the conclusion is rational and largely justifiable but limited by the d…
View article: Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020
Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020 Open
This study describes changes in blood donor demographics and seroreactivity after testing of blood donations for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies began and was publicized in the US in mid-June 2020.
View article: Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers
Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers Open
Background Risk assessments of transfusion‐transmitted emerging infectious diseases (EIDs) are complicated by the fact that blood donorsʼ demographics and behaviors can be different from the general population. Therefore, when assessing po…
View article: Technical solutions to social issues?
Technical solutions to social issues? Open
See article on page 267–276, in this issue